Sentient Biogenix Tirzepatide 30 mg vial

Tirzepatide 30mg

$140.00 CAD

Tirzepatide is a dual-agonist peptide that activates both the GIP and GLP-1 receptors, letting investigators study incretin signalling across two pathways in a single molecule — the dual-agonist benchmark against which single- and triple-agonist candidates are measured.

Pep-Pedia link

In stock

Volume pricing — mix and match any vials

Discount is applied automatically in your cart. Any combination of vials counts toward the tier — they do not have to be the same compound. Syringes and swabs are excluded.

This ships as dry powder. It takes 3 mL of bacteriostatic water to reconstitute, and you will need syringes and swabs to draw and dose it. The Research Starter Kit has all of it in one line.

Category:

Description

Tirzepatide is a long-acting synthetic peptide that activates both the GIP and GLP-1 receptors, studied for its effects on appetite signalling, glucose homeostasis, body-composition endpoints and hepatic fat in obesity and diabetes research models. Supplied as a 30 mg lyophilised vial.

*Sentient Biogenix products are intended solely for non-clinical laboratory research. This product is not an approved medicine, is not manufactured or tested to pharmaceutical standards, and is not for human or animal consumption, nor for diagnostic, therapeutic, or clinical use. Approved tirzepatide medicines exist and are prescription-only; this is not one of them.

Share your thoughts!

Let us know what you think...

Leave a Review Ask a Question Post a Video Post a Photo

What others are saying

There are no contributions yet.

×

Login

Register


Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.

Continue as a Guest

Don't have an account? Sign Up

Continue as a Guest